Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.

Whynes DK, Mangham CM, Balfour TW, Scholefield JH.

Gut. 2010 Aug;59(8):1088-93. doi: 10.1136/gut.2009.192971.

PMID:
20639252
2.

Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.

Oliphant R, McLoone P, Morrison D.

Gut. 2011 Aug;60(8):1163-4. doi: 10.1136/gut.2010.233783. Epub 2010 Dec 29. No abstract available.

PMID:
21193450
3.

Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

Mandel JS, Church TR, Ederer F, Bond JH.

J Natl Cancer Inst. 1999 Mar 3;91(5):434-7.

PMID:
10070942
4.

Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.

Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD.

Gut. 2012 Jul;61(7):1036-40. doi: 10.1136/gutjnl-2011-300774. Epub 2011 Nov 3.

PMID:
22052062
5.

Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.

Lindholm E, Brevinge H, Haglind E.

Br J Surg. 2008 Aug;95(8):1029-36. doi: 10.1002/bjs.6136.

PMID:
18563785
6.
7.

The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.

Robinson MH, Hardcastle JD, Moss SM, Amar SS, Chamberlain JO, Armitage NC, Scholefield JH, Mangham CM.

Gut. 1999 Oct;45(4):588-92.

8.

Early detection of colorectal cancer with faecal occult blood test screening.

Paimela H, Malila N, Palva T, Hakulinen T, Vertio H, Järvinen H.

Br J Surg. 2010 Oct;97(10):1567-71. doi: 10.1002/bjs.7150.

PMID:
20603855
9.

Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.

Faivre J, Tazi MA, El Mrini T, Lejeune C, Benhamiche AM, Dassonville F.

Br J Cancer. 1999 Feb;79(3-4):680-3.

10.

A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese.

Wong MC, Tsoi KK, Ng SS, Lou VW, Choi SY, Ling KW, Chan FK, Griffiths SM, Sung JJ.

Aliment Pharmacol Ther. 2010 Jul;32(1):74-82. doi: 10.1111/j.1365-2036.2010.04312.x. Epub 2010 Mar 25.

11.

Chinese peoples' perceptions of colorectal cancer screening: a New Zealand perspective.

Bong G, McCool J.

N Z Med J. 2011 Mar 25;124(1331):29-38.

PMID:
21725410
12.

Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening.

Mapp TJ, Hardcastle JD, Moss SM, Robinson MH.

Br J Surg. 1999 Oct;86(10):1286-91.

PMID:
10540135
13.

Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.

Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S; Japan Public Health Center-based Prospective Study.

Cancer Detect Prev. 2007;31(1):3-11. Epub 2007 Feb 7.

PMID:
17289293
14.

Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood test.

Kronborg O, Fenger C, Worm J, Pedersen SA, Hem J, Bertelsen K, Olsen J.

Scand J Gastroenterol. 1992;27(1):47-52.

PMID:
1736342
15.

Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process.

Robinson MH, Rodrigues VC, Hardcastle JD, Chamberlain JO, Mangham CM, Moss SM.

J Med Screen. 2000;7(2):97-8.

PMID:
11002450
16.

A 25-year follow-up of a population screened with faecal occult blood test in Finland.

Malila N, Hakama M, Pukkala E.

Acta Oncol. 2007;46(8):1103-6.

PMID:
17851857
17.

Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.

Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG.

J Natl Cancer Inst. 1993 Aug 18;85(16):1311-8.

PMID:
8340943
18.

Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.

Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, Reijerink JC, Habbema JD, Essink-Bot ML, Kuipers EJ.

Eur J Cancer. 2010 Jul;46(11):2059-66. doi: 10.1016/j.ejca.2010.03.022. Epub 2010 Jun 4.

PMID:
20621736
19.

Screening for colorectal cancer reduces emergency admissions.

Scholefield JH, Robinson MH, Mangham CM, Hardcastle JD.

Eur J Surg Oncol. 1998 Feb;24(1):47-50.

PMID:
9542516
20.

Risk for colorectal cancer in elderly persons and possible methodologies for their screening.

Rozen P, Shabtai EI, Liphshitz I, Barchana M.

Eur J Gastroenterol Hepatol. 2011 May;23(5):431-7. doi: 10.1097/MEG.0b013e328345bc38.

PMID:
21448071

Supplemental Content

Support Center